The Lancet HIV
-
1
[Editorial] Fiji's national HIV emergency
-
2
[Culture] Charting the USA's spiralling HIV response
-
3
[Culture] Using circus skills to tell stories about HIV/AIDS
-
4
[Articles] Epidemiological trends of HIV among individuals aged 15–54 years in South Africa from 2004 to 2025: a population-based, longitudinal cohort study
-
5
[Articles] Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study
-
6
[Comment] Reimagining HIV service integration
-
7
[Articles] Virological failure and treatment interruption among people with unsuppressed viral load on antiretroviral therapy: a cross-sectional analysis of Population-based HIV Impact Assessment surveys in seven sub-Saharan African countries
-
8
[Feature] Early lessons from lenacapavir PrEP roll-out in Zimbabwe
-
9
[Articles] Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study
-
10
[Articles] Trends in HIV-1 transmission in Switzerland: a retrospective molecular epidemiology study
The Lancet Infectious Diseases
-
1
[Media Watch] Who fills the silence in a crisis
-
2
[Newsdesk] Disruption of HIV services in Ukraine
-
3
[Correspondence] Cross-neutralisation of authentic Ebola virus and Bundibugyo virus following natural infection or Ervebo vaccination
-
4
[Correspondence] Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination
-
5
[Personal View] Second-season observations after prophylaxis in the evaluation of the impact of nirsevimab in Galicia (NIRSE-GAL) study: mechanistic interpretation and implications for respiratory syncytial virus prevention strategy
-
6
[Personal View] Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks
-
7
[Media Watch] Putting emotion back into pandemic numbers
-
8
[Corrections] Correction to Lancet Infect Dis 2026; published online Oct 1. https://doi.org/10.1016/S1473-3099(26)00470-6
-
9
[Media Watch] Who fills the silence in a crisis
-
10
[Articles] Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace)
The Lancet Neurology
-
1
[Review] The role of lifestyle interventions in symptom management and disease modification in Parkinson's disease
-
2
[Comment] Advances in understanding sudden unexpected death in people with drug-resistant epilepsy
-
3
[Articles] Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study
The Lancet Microbe
-
1
[Comment] Bourbon virus: an expanding tick-borne threat hidden by diagnostic blind spots
-
2
[Correspondence] Airborne transmission risk of monkeypox virus: the importance of infection-competent virus
-
3
[Articles] Implementation of rapid pan-microbial metagenomics in paediatric intensive care: a single-centre, prospective, observational study
-
4
[Articles] Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus vaccine in children aged 6–18 months by baseline serostatus: a multicentre, randomised, placebo-controlled, phase 1/2 trial
-
5
[Comment] From reactive to proactive: rethinking parasite controls in the fresh produce chain
-
6
[Review] Role of the urobiome in urinary tract infections: current knowledge and research prospects
-
7
[Personal View] The future of cholera genomics through the lens of clinical, public health, and research practitioners in Africa
-
8
[Articles] Regional expansion and adaptive evolution of multidrug-resistant Candida tropicalis in China: a retrospective, multicentre, genomic study
-
9
[News] US Executive Order on child vaccines deemed unscientific
-
10
[News] H5N1 in Australia: psychology, penguins, and preparedness
The Lancet Oncology
-
1
[News] Russia slashes federal cancer funding to spend on defence
-
2
[News] Europe has fallen behind in number of oncology trials
-
3
[Comment] Time to say goodbye to full-field digital mammography in population-based screening?
-
4
[Articles] Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial
-
5
[News] Impact of the Trump Administration on the Affordable Care Act
-
6
[Articles] Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial
-
7
[News] New UK National Cancer Board
-
8
[News] 2026 ASTRO Annual Meeting
-
9
[News] Could Brazil's tuberculosis network detect lung cancer earlier?
-
10
[News] Viet Nam considers health insurance for cancer screening
The Lancet Planetary Health
-
1
[Feature] The evidence gap behind the data centre boom
-
2
[Comment] Early career insights on boundary crossing for planetary health and a just future
-
3
[Articles] Cause-specific hospital admissions associated with short-term PM2·5 exposure: a multicountry time-series analysis
-
4
[Personal View] Seven principles for a critical transdisciplinary approach to planetary health
-
5
[Corrections] Correction to Lancet Planet Health 2026; 10: 101416
-
6
[Comment] From El Niño–Southern Oscillation warning to proportionate health action
-
7
[Viewpoint] Navigating global health futures under the Shared Socioeconomic Pathways
-
8
[News] Planetary Health Research Digest
-
9
[Articles] Effects of a 3-day simulated heatwave on physiological and functional outcomes in older adults in Canada: a single-site randomised crossover trial
-
10
[Comment] International organisations agree on the importance of surveillance, but not on its definition
The Lancet Psychiatry
-
1
[Correspondence] Open Dialogue: challenges in interpreting the ODDESSI trial results
-
2
[Correspondence] Open Dialogue: challenges in interpreting the ODDESSI trial results
-
3
[Correspondence] Open Dialogue: challenges in interpreting the ODDESSI trial results
-
4
[Comment] Towards a convergent biomarker and treatment for obsessive-compulsive disorder
-
5
[Corrections] Correction to Lancet Psychiatry 2026; 13: 852–60
-
6
[Personal View] From discovery to proof: a Translation Evidence Map for precision psychiatry
-
7
[Articles] Sex differences in the efficacy, acceptability, and tolerability of antipsychotics in people with acute schizophrenia: individual participant data pairwise, dose–response, and network meta-analyses
-
8
[Comment] Challenges and implications of enabling community-led mental health initiatives
-
9
[Comment] Open Dialogue after ODDESSI: an odyssey of enthusiasm, expectancy, and evidence
-
10
[Editorial] Sending the right message
The Lancet Public Health
-
1
[Articles] Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study
-
2
[Health Policy] The 2025 China report of the Lancet Countdown on health and climate change: empowering cities for synergistic action
-
3
[Articles] Health and economic effects of increased taxation on tobacco, alcohol, and sugar-sweetened beverages in China: a modelling study
-
4
[Articles] Seroepidemiology of hepatitis C virus infection in people aged 1–69 years in China: a national, cross-sectional study
-
5
[Articles] The effect of healthy lifestyles and social determinants on independent life expectancy and sex differences in China: evidence from a 13-year cohort study
-
6
[Review] Sleep health in China: status, challenges, and promotion strategies
The Lancet Regional Health – Americas
-
1
[Viewpoint] Resilience in cancer control in times of crisis: a vision for action in Brazil
-
2
[Case Report] Diagnostic and therapeutic challenges of suspected familial insulinomatosis in a low-resource setting: a case report
-
3
[Articles] Gynecologic and reproductive morbidity during adolescence and subsequent chronic pelvic pain in adulthood: a population-based matched cohort study
-
4
[Articles] Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial
-
5
[Viewpoint] Not every home is a haven: how policy and practice can address vulnerabilities in home-based care
-
6
[Series] An echocardiographic appreciation of rheumatic heart disease: phenotypic variability of valvular involvement and its prognostic implications
-
7
[Series] Medical, interventional, and surgical management of rheumatic heart disease
-
8
[Series] Acute rheumatic fever and rheumatic heart disease in Latin America: a contemporary review of epidemiology
-
9
[Articles] Alcohol-attributable cancer mortality in the United States, 1990–2023: a secondary analysis of Global Burden of Disease data
-
10
[Personal View] Less than what? Response to alcohol consumption recommendations in the 2025–2030 dietary guidelines for Americans